Werbung
Werbung

ORMP

ORMP logo

Oramed Pharmaceuticals Inc.

2.91
USD
Gesponsert
+0.06
+2.18%
02. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

2.99

+0.08
+2.68%

ORMP Ergebnisberichte

Positives Überraschungsverhältnis

ORMP übertreffen die 11 der letzten 15Schätzungen.

73%

Nächster Bericht

in 3 Tagen
Datum des nächsten Berichts
08. Jan. 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/
--
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/
--
Implizierte Änderung von Q1 25 (Revenue/ EPS)
--
/
--

Oramed Pharmaceuticals Inc. earnings per share and revenue

On 13. Nov. 2025, ORMP reported earnings of 1.12 USD per share (EPS) for Q3 25, beating the estimate of -0.04 USD, resulting in a 2845.10% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -2.92% price change (close before vs. close after earnings).
Looking ahead to Q1 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q3 2025, Oramed Pharmaceuticals Inc. reported EPS of $1.12, beating estimates by 2845.1%, and revenue of $0.00, 0% as expectations.
The stock price moved down -2.92%, changed from $2.40 before the earnings release to $2.33 the day after.
The next earning report is scheduled for 08. Jan. 2026.
Based on -- analysts, Oramed Pharmaceuticals Inc. is expected to report EPS of -- and revenue of -- for Q1 2026.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung